Grandeur Peak Global Advisors’s Treace Medical Concepts TMCI Stock Holding History

Grandeur Peak Global Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-37,399	Closed	-$251K	–	114
2025 Q3	$251K	Hold	37,399	–	–	0.03%	101
2025 Q2	$220K	Sell	37,399 -8,231	-18%	-$53.6K	0.03%	103
2025 Q1	$383K	Hold	45,630	–	–	0.04%	103
2024 Q4	$339K	Hold	45,630	–	–	0.03%	121
2024 Q3	$265K	Buy	45,630 +24,426	+115%	+$157K	0.02%	127
2024 Q2	$141K	Sell	21,204 -34,075	-62%	-$275K	0.01%	127
2024 Q1	$721K	Buy	55,279 +34,075	+161%	+$454K	0.06%	108
2023 Q4	$270K	Buy	+21,204	New	+$214K	0.02%	111

Other funds holding TMCI

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Grandeur Peak Global Advisors's TMCI Position: Q4 2025 in Review

Grandeur Peak Global Advisors sold out of Treace Medical Concepts (TMCI) in Q4 2025, closing a stake of 37,399 shares — an estimated $251K sold.

Grandeur Peak Global Advisors first reported a position in TMCI in Q4 2023 and held it in 8 quarters. The position peaked at $721K in Q1 2024. 115 funds tracked by Wall St. Rank hold TMCI as of Q4 2025.

Grandeur Peak Global Advisors reported no remaining Treace Medical Concepts position as of Q4 2025 after selling out during the quarter.
Grandeur Peak Global Advisors sold 37,399 Treace Medical Concepts shares in Q4 2025, an estimated $251K.
Grandeur Peak Global Advisors first reported a position in Treace Medical Concepts in Q4 2023 and held it in 8 quarters.
Grandeur Peak Global Advisors's Treace Medical Concepts position peaked at $721K in Q1 2024.
115 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2025.

Based on Grandeur Peak Global Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.